Insider · CIK 0001874199

Washburn Theodore James Jr.

CIK 0001874199 Name as filed on the most recent filing

Filed as Washburn Theodore James Jr. (19)

24 transaction lines · from 19 filings · filed 2022-02-16 to 2026-03-05 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

24 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2026-03-03 S, Open-market sale Agios Pharmaceuticals, Inc.AGIO 152,255, disposed Open Form 4 filing 0001439222-26-000046
2026-03-02 S, Open-market sale Agios Pharmaceuticals, Inc.AGIO 3 lines 64,378, disposed Open Form 4 filing 0001439222-26-000034
2025-09-05 S, Open-market sale Agios Pharmaceuticals, Inc.AGIO 315,091, disposed Open Form 4 filing 0001439222-25-000102
2025-03-03 S, Open-market sale Agios Pharmaceuticals, Inc.AGIO 3 lines 58,819, disposed Open Form 4 filing 0001439222-25-000011
2025-02-05 S, Open-market sale Agios Pharmaceuticals, Inc.AGIO 78,134, disposed Open Form 4 filing 0001439222-25-000004
2024-11-08 S, Open-market sale Agios Pharmaceuticals, Inc.AGIO 43,301, disposed Open Form 4 filing 0001439222-24-000144
2024-06-03 S, Open-market sale Agios Pharmaceuticals, Inc.AGIO 60,459, disposed Open Form 4 filing 0001439222-24-000071
2024-03-05 S, Open-market sale Agios Pharmaceuticals, Inc.AGIO 60,738, disposed Open Form 4 filing 0001439222-24-000056
2024-03-05 S, Open-market sale Agios Pharmaceuticals, Inc.AGIO 2 lines 39,540, disposed Open Form 4 filing 0001439222-24-000050
2024-02-20 S, Open-market sale Agios Pharmaceuticals, Inc.AGIO 13,422, disposed Open Form 4 filing 0001439222-24-000037
2024-02-14 S, Open-market sale Agios Pharmaceuticals, Inc.AGIO 6,863, disposed Open Form 4 filing 0001439222-24-000026
2023-08-07 S, Open-market sale Agios Pharmaceuticals, Inc.AGIO 74,096, disposed Open Form 4 filing 0001439222-23-000121
2023-08-01 S, Open-market sale Agios Pharmaceuticals, Inc.AGIO 32,352, disposed Open Form 4 filing 0001439222-23-000113
2023-03-03 S, Open-market sale Agios Pharmaceuticals, Inc.AGIO 12,242, disposed Open Form 4 filing 0001439222-23-000053
2023-02-16 S, Open-market sale Agios Pharmaceuticals, Inc.AGIO 6,340, disposed Open Form 4 filing 0001439222-23-000028
2023-02-14 S, Open-market sale Agios Pharmaceuticals, Inc.AGIO 14,409, disposed Open Form 4 filing 0001439222-23-000026
2022-02-25 S, Open-market sale Agios Pharmaceuticals, Inc.AGIO 3,240, disposed Open Form 4 filing 0001439222-22-000025
2022-02-16 S, Open-market sale Agios Pharmaceuticals, Inc.AGIO 7,179, disposed Open Form 4 filing 0001439222-22-000013
2022-02-14 S, Open-market sale Agios Pharmaceuticals, Inc.AGIO 15,750, disposed Open Form 4 filing 0001439222-22-000009

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
Relationships on this page
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 0
  • Open-market sale 24
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Washburn Theodore James Jr., insider transactions. Retrieved 2026-08-24 from https://ebomi.com/insider/0001874199

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.